首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1842135

神经科学领域人工智慧的全球市场

AI in Neurology: Global Markets

出版日期: 2025年10月08日 | 出版商:

BCC Research | 英文 164 Pages | 订单完成后即时交付

价格

简介目录图表

预计到 2030 年，全球神经科学人工智慧市场规模将达到 25 亿美元，从 2024 年的 5.636 亿美元成长到 2025 年的 7.056 亿美元，预测期内的复合年增长率为 28.9%。

预计北美市场将从2024年的2.661亿美元和2025年的3.436亿美元成长至2030年的14亿美元，复合年增长率为32.6%。预计亚太市场将从2024年的8,450万美元和2025年的1.065亿美元成长至2030年的3.913亿美元，复合年增长率为29.7%。

本报告调查了神经科学领域的全球人工智慧市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测以及各个细分市场和地区的详细分析。

概述
市场驱动因素
神经系统疾病盛行率上升
早期诊断和精准医疗的需求
神经影像学和数据分析技术的进展
政府和监管支持
市场限制
农村和中低收入国家的神经科短缺
人工智慧整合高成本
市场机会
人工智慧在神经病学领域的未来潜力：诊断创新
人工智慧驱动的个人化神经治疗计划
市场挑战
神经科学领域的人工智慧工具缺乏标准化、检验和透明度
神经医学系统的数据碎片化

第四章：监理现状

监管情景
美国神经病学人工智慧监管格局：设备
美国神经病学领域人工智慧的监管格局：製药和生技药品的人工智慧/机器学习工具
欧洲神经科学领域人工智慧的监管格局
日本神经科学领域人工智慧的监管情况
印度神经科学领域人工智慧的监管格局

第五章新兴技术与专利分析

关键要点
神经病学中的生成式人工智慧：临床支援和高级知识利用
人工智慧在神经病学核神经造影的应用
将人工智慧增强型 BCI（脑机介面）与传统和补充神经医学结合
在认知功能和心理健康领域利用人工智慧工具
LLM（大规模语言模型）和NLP（自然语言处理）在神经科学领域的新兴作用
神经人工智慧的新兴趋势
专利分析
主要发现

第六章市场区隔分析

细分市场
按产品类型分類的市场细分
关键要点
神经肿瘤学和神经发炎疾病中的人工智慧
人工智慧在神经血管和创伤性脑损伤的应用
人工智慧在癫痫和功能性脑部疾病的应用
脊柱和运动障碍中的人工智慧
人工智慧在神经发育和精神疾病的应用
市场区隔：按应用
关键要点
神经影像分析
脑电图（EEG）
临床决策支持
药物研发
其他的
市场区隔：按技术
关键要点
机器学习和深度学习
自然语言处理（NLP）
其他的
市场区隔：按最终用户
关键要点
医院和诊所
诊断中心
研发中心
地理分布
市场区隔：按地区
关键要点
北美洲
欧洲
亚太地区
南美洲
中东和非洲

第七章竞争讯息

关键要点
企业市场占有率分析
关键发展和策略
伙伴关係与合作
获得
业务扩展
产品发布和核准

第八章：环境、社会与管治（ESG）视角

ESG：简介
人工智慧在神经科学中对提高永续性和投资回报的作用
神经科学领域人工智慧的 ESG永续性：主要企业的倡议
ESG风险评估
BCC 的结论

第九章附录

调查方法
参考
简称
公司简介
ACTIV SURGICAL
AIRAMED GMBH
BRAINOMIX
BRAINQ TECHNOLOGIES LTD.
CANON INC.
GE HEALTHCARE
KONINKLIJKE PHILIPS NV
MEDTRONIC
NEOSOMA INC.
NEURALINK
NEUROX
NVIDIA CORP.
QURE.AI
SIEMENS HEALTHINEERS AG
VIZ.AI INC.

简介目录图表

Product Code: AIT018A

The global market for AI in neurology was valued at $563.6 million in 2024 and is estimated to increase from $705.6 million in 2025 to reach $2.5 billion by 2030, at a compound annual growth rate (CAGR) of 28.9% from 2025 through 2030.

The North American market for AI in neurology was valued at $266.1 million in 2024 and is estimated to increase from $343.6 million in 2025 to reach $1.4 billion by 2030, at a CAGR of 32.6% from 2025 through 2030.

The Asia-Pacific market for AI in neurology was valued at $84.5 million in 2024 and is estimated to increase from $106.5 million in 2025 to reach $391.3 million by 2030, at a CAGR of 29.7% from 2025 through 2030.

Report Scope

The report provides an overview of the global market for AI in neurology and analyzes market trends. It includes global revenue (in $ millions) with 2024 as the base year, estimated data for 2025, and projections from 2026 to 2030. The market is segmented based on type, end-user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America, focusing on major countries in these regions.

The report provides an in-depth analysis of the global AI in neurology market, emphasizing the major driving forces and emerging technologies shaping this evolving field. It explores how artificial intelligence (AI) transforms neurology through enhanced diagnostic capabilities, early disease detection, personalized treatment planning and remote patient monitoring for neurological conditions such as Alzheimer's, Parkinson's, stroke and epilepsy.

This report analyzes AI adoption and use cases in neurology, highlighting geographic trends across North America, Europe, Asia-Pacific, South America and MEA. It also examines AI disruption across industry verticals and value chain stages, while presenting market spending patterns, investment forecasts, major company expenditures and venture capital funding in AI-driven neurology technologies.

The report examines the environmental, social and corporate governance (ESG) aspects influencing the adoption and ethical use of AI in neurology, reviews recent patent filings and innovation trends that reflect technological advancements in AI-based neuroimaging, brain-computer interfaces, digital therapeutics and wearable neurological devices.

A comprehensive competitive landscape analysis ranks and evaluates the market share of major players globally, highlighting their strategic initiatives, R&D investments and technological strengths in AI neurology solutions. The report concludes with detailed company profiles of key market participants, offering insights into their product portfolios, partnerships, acquisitions and contributions to the advancement of AI in neurological healthcare.

Report Includes

52 data tables and 69 additional tables
An overview of the global market for AI in neurology
In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, and projected CAGRs through 2030
Evaluation of the current market size and revenue growth prospects specific to AI in neurology, accompanied by a market share analysis by product type, application, end-user industry and region
Analysis of current and future demand in the global neurology market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
Analysis of drivers, challenges and opportunities affecting market growth
Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
Market share analysis of the key market participants in the neurology market, along with their research priorities, product portfolios, global rankings and competitive landscape
Company profiles of major players within the industry, including Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Nvidia Corp., and Canon Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
AI-Driven Personalization in Neurology: Advancing Prognosis, Treatment and Outcomes
Porter's Five Forces Analysis
Competitive Rivalry (High)
Threat of New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Low to Moderate)
Conclusion
Macro-Economic Factor Analysis
Economic Growth and Healthcare Spending
Technological Advancement and R&D Investment
Regulatory Environment and Policy Support
Demographic Trends and Disease Burden
Labor Market and Talent Availability

Chapter 3 Market Dynamics

Overview
Market Drivers
Rising Prevalence of Neurological Disorders
Demand for Early Diagnosis and Precision Medicine
Advancements in Neuroimaging and Data Analytics
Support from Governments and Regulatory Agencies
Market Restraints
Neurological Workforce Paucity in Rural Areas and LMICs
High Cost of AI Integration
Market Opportunities
Future Opportunities for AI in Neurology: Revolutionizing Diagnostics
AI in Personalized Neurological Treatment Plans
Market Challenges
Lack of Standardized Validation and Transparency in AI-Based Neurology Tools
Data Fragmentation Across Neurological Care Systems

Chapter 4 Regulatory Landscape

Regulatory Scenario
Regulatory Landscape in the U.S. for AI in Neurology: Devices
Regulatory Landscape in the U.S. for AI in Neurology: AI/ML tools in Drugs and Biologics
Regulatory Landscape in Europe for AI in Neurology
Regulatory Landscape in Japan for AI in Neurology
Regulatory Landscape in India for AI in Neurology

Chapter 5 Emerging Technologies and Patent Analysis

Key Takeaways
Generative AI in Neurology: Advancing Clinical Support and Knowledge Performance
AI for Nuclear Neuroimaging in Neurology
Integrating AI-Enhanced Brain-Computer Interfaces with Traditional and Complementary Neurology
AI Tools for Cognitive and Mental Health in Neurology
Emerging Role of LLMs and NLP in Neurology AI Applications
Emerging Trends in AI for Neurology
Patent Analysis
Key Findings

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown by Product Type
Key Takeaways
AI in Neuro-Oncology and Neuroinflammatory Disorders
AI in Neurovascular and Traumatic Brain Injury
AI in Epilepsy and Functional Brain Disorders
AI in Spinal and Movement Disorders
AI in Neurodevelopmental and Psychiatric Conditions
Market Breakdown by Application
Key Takeaways
Neuro Imaging Analysis
Electroencephalography (EEG) Interpretation
Clinical Decision Support
Drug Discovery and Development
Others
Market Breakdown by Technology
Key Takeaways
Machine Learning and Deep Learning
Natural Language Processing (NLP)
Others
Market Breakdown, by End User
Key Takeaways
Hospitals and Clinics
Diagnostics Centers
Research and Development Centers
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Chapter 7 Competitive Intelligence

Key Takeaways
Company Share Analysis
Key Developments and Strategies
Partnerships and Collaborations
Acquisition
Business Expansions
Product Launches, Approval

Chapter 8 Environmental, Social and Governance (ESG) Perspective

Introduction to ESG
The Role of AI in Neurology for Advancing Sustainability and Investment Impact
ESG Sustainability in AI for Neurology: Efforts, by Major Players
ESG Risk Ratings
Concluding Remarks from BCC

Chapter 9 Appendix

Research Methodology
References
Abbreviations
Company Profiles
ACTIV SURGICAL
AIRAMED GMBH
BRAINOMIX
BRAINQ TECHNOLOGIES LTD.
CANON INC.
GE HEALTHCARE
KONINKLIJKE PHILIPS N.V.
MEDTRONIC
NEOSOMA INC.
NEURALINK
NEUROX
NVIDIA CORP.
QURE.AI
SIEMENS HEALTHINEERS AG
VIZ.AI INC.
Few Emerging Start-ups/Market Disruptors

简介目录图表

List of Tables

Summary Table : Global Market for AI in Neurology, by Region, Through 2030
Table 1 : Benefits of Artificial Intelligence (AI) in Neurology
Table 2 : The Neurologist's AI Armamentarium
Table 3 : FDA Cleared Some Neuroimaging AI Products
Table 4 : Porter's Five Forces: Rating Scale
Table 5 : Ten Neurological Conditions that Accounted for the Greatest DALYs in 2021
Table 6 : FDA Cleared AI Algorithms, by Specialty, as of May 30, 2025
Table 7 : Progressive Reduction of General Neurologists, 2014-2023
Table 8 : Comparison Between Traditional Accuracy and AI-Based Accuracy
Table 9 : AI-Driven Precision Neurological Care: Emerging Tasks and Tool Descriptions
Table 10 : Emerging Applications of AI Techniques in the Neurological Sciences
Table 11 : Select Published Patents on AI in Neurology, January 2025-July 2025
Table 12 : Global Market for AI in Neurology, by Product Type, Through 2030
Table 13 : CE Marked Deep Learning Algorithms in Neuroinflammatory Diseases
Table 14 : Global Market for AI in Neuro-Oncology and Neuroinflammatory Disorders, by Region, Through 2030
Table 15 : Global Market for AI in Neurovascular and Traumatic Brain Injury, by Region, Through 2030
Table 16 : Global Market for AI in Epilepsy and Functional Brain Disorders, by Region, Through 2030
Table 17 : Global Market for AI in Spinal and Movement Disorders, by Region, Through 2030
Table 18 : Global Market for AI in Neurodevelopmental and Psychiatric Conditions, by Region, Through 2030
Table 19 : Global Market for AI in Neurology, by Application, Through 2030
Table 20 : Global Market for AI in Neuroimaging Analysis, by Region, Through 2030
Table 21 : Global Market for AI in Electroencephalography (EEG) Interpretation, by Region, Through 2030
Table 22 : Global Market for AI in Clinical Decision Support, by Region, Through 2030
Table 23 : AI-Enabled Drugs Entering the Clinical Phase
Table 24 : Global Market for AI in Drug Discovery and Development, by Region, Through 2030
Table 25 : Global Market for AI in Other Applications, by Region, Through 2030
Table 26 : Global Market for AI in Neurology, by Technology, Through 2030
Table 27 : Global Market for ML/DL in Neurology, by Region, Through 2030
Table 28 : Global Market for NLP in Neurology, by Region, Through 2030
Table 29 : Global Market for Other AI-Based Technologies in Neurology, by Region, Through 2030
Table 30 : Global Market for AI in Neurology, by End User, Through 2030
Table 31 : Global Market for Hospitals and Clinics for AI in Neurology, by Region, Through 2030
Table 32 : Global Market for Diagnostics Centers for AI in Neurology, by Region, Through 2030
Table 33 : Global Market for Research and Development Centers for AI in Neurology, by Region, Through 2030
Table 34 : Global Market for AI in Neurology, by Region, Through 2030
Table 35 : North American Market for AI in Neurology, by Product Type, Through 2030
Table 36 : North American Market for AI in Neurology, by Application, Through 2030
Table 37 : North American Market for AI in Neurology, by Technology, Through 2030
Table 38 : North American Market for AI in Neurology, by End User, Through 2030
Table 39 : North American Market for AI in Neurology, by Country, Through 2030
Table 40 : European Market for AI in Neurology, by Product Type, Through 2030
Table 41 : European Market for AI in Neurology, by Application, Through 2030
Table 42 : European Market for AI in Neurology, by Technology, Through 2030
Table 43 : European Market for AI in Neurology, by End User, Through 2030
Table 44 : European Market for AI in Neurology, by Country, Through 2030
Table 45 : Asia-Pacific Market for AI in Neurology, by Product Type, Through 2030
Table 46 : Asia-Pacific Market for AI in Neurology, by Application, Through 2030
Table 47 : Asia-Pacific Market for AI in Neurology, by Technology, Through 2030
Table 48 : Asia-Pacific Market for AI in Neurology, by End User, Through 2030
Table 49 : Asia-Pacific Market for AI in Neurology, by Country, Through 2030
Table 50 : South American Market for AI in Neurology, by Product Type, Through 2030
Table 51 : South American Market for AI in Neurology, by Application, Through 2030
Table 52 : South American Market for AI in Neurology, by Technology, Through 2030
Table 53 : South American Market for AI in Neurology, by End User, Through 2030
Table 54 : MEA Market for AI in Neurology, by Product Type, Through 2030
Table 55 : MEA Market for AI in Neurology, by Application, Through 2030
Table 56 : MEA Market for AI in Neurology, by Technology, Through 2030
Table 57 : MEA Market for AI in Neurology, by End User, Through 2030
Table 58 : Top 5 Leading Manufacturers of AI in Neurology Market, 2024
Table 59 : Collaborations and Partnerships: AI in Neurology Market, 2023-2025
Table 60 : Acquisition: AI in Neurology Market, 2024 and 2025
Table 61 : Business Expansion Activities of AI in Neurology Market, 2022-2025
Table 62 : Product Launches and FDA Approval Activities of AI in Neurology Market, 2022-2025
Table 63 : AI Ethics Principles
Table 64 : ESG Issues Related to Different AI Applications, 2024
Table 65 : ESG Highlights, by Major Players, 2023
Table 66 : ESG Rankings of Major AI in Neurology Products Manufacturing Companies, 2024
Table 67 : Information Sources for Compiling this Report
Table 68 : Abbreviations Used in the Report
Table 69 : Activ Surgical: Company Snapshot
Table 70 : Activ Surgical: Product Portfolio
Table 71 : Activ Surgical: News/Key Developments, 2022-2024
Table 72 : AIRAmed GmbH: Company Snapshot
Table 73 : AIRAmed GmbH: Product Portfolio
Table 74 : AIRAmed GmbH: News/Key Developments, 2023 and 2024
Table 75 : Brainomix: Company Snapshot
Table 76 : Brainomix: Product Portfolio
Table 77 : Brainomix: News/Key Developments, 2023-2025
Table 78 : BrainQ Technologies Ltd.: Company Snapshot
Table 79 : BrainQ Technologies Ltd.: Product Portfolio
Table 80 : BrainQ Technologies Ltd.: News/Key Developments, 2024 and 2025
Table 81 : Canon Inc.: Company Snapshot
Table 82 : Canon Inc.: Financial Performance, FY 2023 and 2024
Table 83 : Canon Inc.: Product Portfolio
Table 84 : Canon Inc.: News/Key Developments, 2023 and 2024
Table 85 : GE HealthCare: Company Snapshot
Table 86 : GE HealthCare: Financial Performance, FY 2023 and 2024
Table 87 : GE HealthCare: Product Portfolio
Table 88 : GE HealthCare: News/Key Developments, 2024 and 2025
Table 89 : Koninklijke Philips N.V.: Company Snapshot
Table 90 : Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
Table 91 : Koninklijke Philips N.V.: Product Portfolio
Table 92 : Koninklijke Philips N.V.: News/Key Developments, 2023-2025
Table 93 : Medtronic: Company Snapshot
Table 94 : Medtronic: Financial Performance, FY 2023 and 2024
Table 95 : Medtronic: Product Portfolio
Table 96 : Medtronic: News/Key Developments, 2023-2025
Table 97 : Neosoma Inc.: Company Snapshot
Table 98 : Neosoma Inc.: Product Portfolio
Table 99 : Neosoma Inc.: News/Key Developments, 2022 and 2023
Table 100 : Neuralink: Company Snapshot
Table 101 : Neuralink: Product Portfolio
Table 102 : Neuralink: News/Key Developments, 2023-2025
Table 103 : NeuroX: Company Snapshot
Table 104 : NeuroX: Product Portfolio
Table 105 : NeuroX: News/Key Developments, 2022-2025
Table 106 : NVIDIA Corp.: Company Snapshot
Table 107 : NVIDIA Corp.: Financial Performance, FY 2023 and 2024
Table 108 : NVIDIA Corp.: Product Portfolio
Table 109 : NVIDIA Corp.: News/Key Development, 2025
Table 110 : Qure.ai: Company Snapshot
Table 111 : Qure.ai: Product Portfolio
Table 112 : Qure.ai: News/Key Developments, 2024 and 2025
Table 113 : Siemens Healthineers AG: Company Snapshot
Table 114 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 115 : Siemens Healthineers AG: Product Portfolio
Table 116 : Siemens Healthineers AG: Key Developments, 2023-2025
Table 117 : VIZ.ai Inc.: Company Snapshot
Table 118 : VIZ.ai Inc.: Product Portfolio
Table 119 : VIZ.ai Inc.: News/Key Developments, 2023-2025
Table 120 : List of a Few Emerging Startups/ Market Disruptors

List of Figures

Summary Figure : Global Market Shares of AI in Neurology, by Region, 2024
Figure 1 : Market Dynamics of AI in Neurology
Figure 2 : Number of Patents on AI in Neurology Documented Over Time, 2021-July 2025
Figure 3 : Shares of Patents on AI in Neurology, by Jurisdiction, 2021-2025
Figure 4 : Global Market Shares of AI in Neurology, by Product Type, 2024
Figure 5 : Global Market Shares of AI in Neurology, by Application, 2024
Figure 6 : Global Market Shares of AI in Neurology, by Technology, 2024
Figure 7 : Global Market Shares of AI in Neurology, by End User, 2024
Figure 8 : Global Market Shares of AI in Neurology, by Region, 2024
Figure 9 : Global Market Shares of AI in Neurology, by Leading Companies, 2024
Figure 10 : AI Can Be Used to MOP Things up in a Sustainability System
Figure 11 : Canon Inc.: Revenue Share, by Business Unit, FY 2024
Figure 12 : Canon Inc.: Revenue Share, by Country/Region, FY 2024
Figure 13 : GE HealthCare: Revenue Share, by Business Unit, FY 2024
Figure 14 : GE HealthCare: Revenue Share, by Country/Region, FY 2024
Figure 15 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2024
Figure 16 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2024
Figure 17 : Medtronic: Revenue Share, by Business Unit, FY 2024
Figure 18 : Medtronic: Revenue Share, by Country/Region, FY 2024
Figure 19 : NVIDIA Corp.: Revenue Share, by Business Unit, FY 2024
Figure 20 : NVIDIA Corp.: Revenue Share, by Country/Region, FY 2024
Figure 21 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2024
Figure 22 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2024

02-2729-4219

+886-2-2729-4219

License/价格

神经科学领域人工智慧的全球市场

AI in Neurology: Global Markets